Novel pharmacological strategies for the treatment of depression

2018/31/B/NZ7/00247

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Katarzyna Młyniec

Number of co-investigators in the project: 4

Call

OPUS 16 – announced on 2018-09-14

Amount awarded
2 075 000 PLN
Project start date
2019-07-26
Project end date
2024-05-25
Project duration
58 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (4)

  1. GPCR Oligomerization as a Target for Antidepressants: Focus on GPR39

    Authors:
    Katarzyna Mlyniec, Dominika Siodłak, Urszula Doboszewska, Gabriel Nowak
    Academic press:
    Pharmacology & Therapeutics (year: 2021, volume: 225, pages: 107842), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharmthera.2021.107842 – link to the publication
  2. Interaction between zinc, GPR39, BDNF and neuropeptides in depression

    Authors:
    Katarzyna Mlyniec
    Academic press:
    Current Neuropharmacology (year: 2021, volume: 19, pages: 2012-2019), Publisher: Bentham Science
    Status:
    Published
    DOI:
    10.2174/1570159X19666210225153404 – link to the publication
  3. Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depression

    Authors:
    Dominika Siodłak, Gabriel Nowak, Katarzyna Mlyniec
    Academic press:
    Brain Research Bulletin (year: 2021, volume: 170, pages: 146-154), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.brainresbull.2021.02.003. – link to the publication
  4. Investigating the role of GPR39 in treatment of stress-induced depression and anxiety

    Authors:
    Siodłak D., Doboszewska U., Nowak G., Wlaź P., Mlyniec K.
    Academic press:
    Psychopharmacology (year: 2025, volume: brak, pages: brak), Publisher: Springer Nature
    Status:
    Published
    DOI:
    10.1007/s00213-024-06736-0 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski